Telemonitoring program for heart failure patients after hospital discharge
Telemonitoring Program With Electronic Alerts to Improve Outcomes in the Vulnerable Phase After Hospitalization for Heart Failure: A Pragmatic Clinical Trial TREAT - Vulnerable HF
NA · Instituto Cardiovascular de Buenos Aires · NCT05972746
This study tests whether a telemonitoring program can help heart failure patients who just left the hospital manage their health better compared to regular follow-up care.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 110 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Instituto Cardiovascular de Buenos Aires (other) |
| Locations | 1 site (Buenos Aires, Ciudad Autónoma De Buenos Aires) |
| Trial ID | NCT05972746 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of a telemonitoring program with an electronic alert system compared to standard treatment for patients recently hospitalized for acute heart failure. The focus is on improving self-care perceptions and monitoring clinical outcomes at three months post-discharge. Participants will be monitored for clinical events, NT-proBNP levels, and the efficacy and safety of recommended medications within 90 days. The study aims to enhance patient management during a vulnerable phase after hospitalization.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have been hospitalized for acute heart failure and can use a smartphone to participate.
Not a fit: Patients with severe psychiatric illnesses, cognitive impairments, or those unable to provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve self-care and clinical outcomes for heart failure patients after hospitalization.
How similar studies have performed: Other studies have shown promising results with telemonitoring approaches in managing heart failure, indicating potential for success in this trial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Hospitalized for acute heart failure (regardless of the level of left ventricular ejection fraction) within 24 hours of discharge, or with a history of hospitalization for acute HF within 10 days prior to randomization. * Own a smartphone (Smartphone) with internet Ability to speak and read Spanish. * Residence in the metropolitan area of Buenos Aires Exclusion Criteria: * Pregnancy * Alcohol or drug abuse * Kidney failure in hemodialysis, * Inability to use the app (Ex: cognitive impairment, lack of social support, lack of ability to communicate) * Active cancer * Life expectancy less than 1 year * Candidates for care home or institutional end of life * Severe psychiatric illness * Planned cardiac surgery * Patient unable or unwilling to give informed consent to participate.
Where this trial is running
Buenos Aires, Ciudad Autónoma De Buenos Aires
- Instituto Cardiovascular de Buenos Aires — Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Heart Failure, Acute Heart Failure, telemonitoring, Vulnerable phase